<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="121129">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02052271</url>
  </required_header>
  <id_info>
    <org_study_id>C13-24</org_study_id>
    <secondary_id>2013-A01404-41</secondary_id>
    <nct_id>NCT02052271</nct_id>
  </id_info>
  <brief_title>Experimental Therapeutics in Essential Tremor Using Cerebellar Transcranial Direct Current Stimulation</brief_title>
  <acronym>ELECTRE2</acronym>
  <official_title>Thérapeutique expérimentale du Tremblement Essentiel Par la Stimulation Transcranienne Par Courant Direct (tDCS) du Cortex Cerebelleux</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether transcranial cathodal direct current
      stimulation (tDCS) delivered over the cerebellum can improve essential tremor.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor)</study_design>
  <primary_outcome>
    <measure>Change from baseline in tremor amplitude on clinical rating scale</measure>
    <time_frame>10 minutes after the end of tDCS</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in tremor amplitude on accelerometric recording</measure>
    <time_frame>During tDCS, 10 mn, 60 mn and 90 mn after the end of tDCS</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in tremor amplitude on electromyographic recordings</measure>
    <time_frame>During tDCS, 10 mn, 60 mn and 90 mn after the end of tDCS</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in tremor amplitude on digitized tablet</measure>
    <time_frame>During tDCS, 10 mn, 60 mn and 90 mn after the end of tDCS</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in tremor amplitude on clinical rating scale</measure>
    <time_frame>During tDCS, 60 mn and 90 mn after the end of tDCS</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline of amplitude of motor evoked potentials elicited by TMS</measure>
    <time_frame>10 mn, 60 mn and 90 mn after tDCS</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Essential Tremor</condition>
  <arm_group>
    <arm_group_label>Essential tremor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 patients with essential tremor</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cathodal cerebellar transcranial direct current stimulation</intervention_name>
    <description>Active stimulation: duration: 20 mn, intensity: 2 mA; localisation : cerebellum; Placebo stimulation: duration: 9 seconds, intensity: 2 mA; localisation cerebellum;</description>
    <arm_group_label>Essential tremor</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years and ≤ 65 years

          -  Important essential tremor (bilateral postural and/or action tremor since more than
             one year)

          -  Normal physical and neurological examination, except for essential tremor

          -  Insufficient efficiency of usual essential tremor's treatment

          -  No treatment altering the cortical excitability

          -  Agreement to use a medically acceptable method of contraception throughout the study
             for female of childbearing potential

          -  mini-mental status score &gt;24

        Exclusion Criteria:

          -  Age &lt; 18 years and &gt; 65 years

          -  Current neurological or psychiatric illness other than essential tremor

          -  Individual who is on medication which is known to lower seizure threshold

          -  Previous history of seizure, loss of conciousness or current active epilepsy

          -  Contraindication for MRI or TMS study

          -  Intake of antiepileptic medications for essential tremor  (barbiturates, gabapentine,
             topiramate, clonazepam), within the 7 days preceeding the first visit

          -  alcohol intake within the 24 hours preceeding the first visit

          -  Pregnancy, breast feeding women and women who are of childbearing age and not
             practicing adequate birth control

          -  Individual who have MMS ≤ 24/30 or patients legally protected or inability to provide
             an informed consent

          -  Simultaneous participation in another clinical trial

          -  Patients who are not enrolled at social security
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emmanuel Flamand-Roze, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut du Cerveau et de la Moelle et Fédération de Neurologie de l'Hôpital Pitié-Salpétrière, Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emmanuelle Apartis, MD, PhD</last_name>
    <phone>+33(0)1 49 28 23 07</phone>
    <email>emmanuelle.apartis@sat.aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institut du Cerveau et de la Moelle, Hôpital Pitié-Salpétrière</name>
      <address>
        <city>Paris</city>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Emmanuel FLAMAND-ROZE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 30, 2014</lastchanged_date>
  <firstreceived_date>January 28, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>essential tremor</keyword>
  <keyword>cerebellum</keyword>
  <keyword>transcranial direct current stimulation</keyword>
  <keyword>electrophysiology</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tremor</mesh_term>
    <mesh_term>Essential Tremor</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
